China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Stock Short Interest Rises 251.4%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a large growth in short interest in September. As of September 15th, there was short interest totaling 65,511 shares, a growth of 251.4% from the August 31st total of 18,642 shares. Based on an average daily volume of 1,496,161 shares, the days-to-cover ratio is currently 0.0 days. Currently, 14.3% of the company’s shares are sold short.

China SXT Pharmaceuticals Trading Up 0.8%

Shares of NASDAQ:SXTC traded up $0.02 during midday trading on Friday, reaching $2.57. The company’s stock had a trading volume of 17,323 shares, compared to its average volume of 802,175. The firm has a 50 day moving average of $15.21 and a 200-day moving average of $107.45. The company has a quick ratio of 7.76, a current ratio of 7.94 and a debt-to-equity ratio of 0.02. China SXT Pharmaceuticals has a 12-month low of $1.78 and a 12-month high of $83,758.80.

China SXT Pharmaceuticals (NASDAQ:SXTC) last issued its quarterly earnings results on Wednesday, July 1st. The company reported $6.84 earnings per share (EPS) for the quarter. The business had revenue of $0.26 million for the quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Wall Street Zen raised shares of China SXT Pharmaceuticals to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings raised shares of China SXT Pharmaceuticals from a “sell (e)” rating to a “sell (e+)” rating in a research note on Wednesday, September 16th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc is a China-based pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicine products. The company’s offerings are designed for use in traditional medicine and health care applications and are marketed primarily in China.

Its product portfolio includes traditional Chinese medicine decoction pieces, finished traditional Chinese medicines and health care products. These products are sold through distribution and retail channels serving pharmacies, medical institutions and other health care-related customers.